Skip to main content

Pear Therapeutics, Inc.

PEARDelisted May 2, 2023
Industry
Services-Health Services
SEC CIK
0001835567

Pear Therapeutics, Inc. was delisted on May 2, 2023; its insiders filed their last Form 4 on Apr 12, 2023; 53 institutions reported holding it in 13F filings for Q1 2023, worth $20.7M in total; no superinvestor held it.

13F holders, Q1 2022

Institutional positions in Pear Therapeutics, Inc. as of Mar 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
48
+23 vs. Q4 2021
Shares held
76.3M
+1.42M (+1.9%) vs. Q4 2021
Total value
$385.3M
−$79.0M (−17.0%) vs. Q4 2021
New holders
26
4 more added
Sold out
3
4 more reduced

Compare with Q4 2021: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting PEAR on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ1 2022: 48 institutions
Q1 2021: 0 institutionsQ2 2021: 0 institutionsQ3 2021: 0 institutionsQ4 2021: 25 institutionsQ1 2022: 48 institutionsQ2 2022: 40 institutionsQ3 2022: 60 institutionsQ4 2022: 64 institutionsQ1 2023: 53 institutionsQ2 2023: 1 institutionQ3 2023: 1 institutionQ4 2023: 1 institutionQ1 2024: 1 institutionQ2 2024: 0 institutionsQ3 2024: 0 institutionsQ4 2024: 0 institutionsQ1 2025: 0 institutionsQ2 2025: 0 institutionsQ3 2025: 0 institutionsQ4 2025: 0 institutionsQ1 2026: 0 institutionsQ2 2026: 0 institutions
Value heldQ1 2022: $385.3M
Q1 2021: $0Q2 2021: $0Q3 2021: $0Q4 2021: $464.3MQ1 2022: $385.3MQ2 2022: $118.4MQ3 2022: $168.1MQ4 2022: $96.3MQ1 2023: $20.7MQ2 2023: $0Q3 2023: $0Q4 2023: $0Q1 2024: $0Q2 2024: $0Q3 2024: $0Q4 2024: $0Q1 2025: $0Q2 2025: $0Q3 2025: $0Q4 2025: $0Q1 2026: $0Q2 2026: $0
Institutions holding PEAR and their total value by quarter
QuarterHoldersValue
Q2 20260$0
Q1 20260$0
Q4 20250$0
Q3 20250$0
Q2 20250$0
Q1 20250$0
Q4 20240$0
Q3 20240$0
Q2 20240$0
Q1 20241$0
Q4 20231$0
Q3 20231$0
Q2 20231$0
Q1 202353$20.7M
Q4 202264$96.3M
Q3 202260$168.1M
Q2 202240$118.4M
Q1 202248$385.3M
Q4 202125$464.3M
Q3 20210$0
Q2 20210$0
Q1 20210$0

Institutions, Q1 2022

Shares, value and share of portfolio for each institution holding Pear Therapeutics, Inc.; share changes are against Q4 2021.

Institutions holding PEAR in Q1 2022
InstitutionSharesValue% of portfolioChange in sharesAction
Temasek Holdings (Private) Ltd26,803,573$135.4M0.57%00.0%Unchanged
5AM Venture Management, LLC18,631,771$94.1M20.55%00.0%Unchanged
SB Global Advisers Ltd12,100,078$61.1M1.92%00.0%Unchanged
Arboretum Ventures, Inc.10,859,050$54.8M44.55%00.0%Unchanged
TB Alternative Assets Ltd.2,071,865$10.5M3.59%00.0%Unchanged
Vanguard Group Inc1,045,443$5.28M0.00%+422,804+67.9%Added
Palantir Technologies Inc.1,000,000$5.05M2.06%00.0%Unchanged
Perceptive Advisors LLC926,232$4.68M0.10%00.0%Unchanged
Sarissa Capital Management LP500,356$2.53M0.24%00.0%Unchanged
EDBI Pte Ltd427,070$2.16M1.44%+699+0.2%Added
BlackRock Inc.416,278$2.10M0.00%+416,278New
Geode Capital Management, LLC284,563$1.44M0.00%+226,510+390.2%Added
Blue Water Life Science Advisors, LLC194,686$983.0K0.47%00.0%Unchanged
HRT Financial LP150,725$761.0K0.01%+150,725New
ExodusPoint Capital Management, LP123,515$624.0K0.01%+123,515New
Citadel Advisors LLC116,701$589.0K0.00%+116,701New
State Street Corp78,715$398.0K0.00%+78,715New
Susquehanna International Group, LLP76,870$388.0K0.00%+76,870New
Northern Trust Corp61,895$313.0K0.00%+61,895New
Alpine Global Management, LLC55,287$279.0K0.07%−569,847−91.2%Reduced
Squarepoint Ops LLC50,837$257.0K0.00%+50,837New
D. E. Shaw & Co., Inc.39,244$198.0K0.00%+39,244New
Sciencast Management LP36,621$190.0K0.04%+36,621New
Millennium Management LLC36,848$186.0K0.00%+36,848New
Jane Street Group, LLC32,352$163.0K0.00%+32,352New
Gsa Capital Partners LLP28,900$146.0K0.02%+28,900New
Shay Capital LLC25,000$126.0K0.05%+25,000New
Bank of America Corp23,353$118.0K0.00%+23,353New
Charles Schwab Investment Management Inc19,890$101.0K0.00%+19,890New
Goldman Sachs Group Inc15,620$79.0K0.00%+15,620New
Diametric Capital, LP13,203$66.0K0.04%+13,203New
Magnus Financial Group LLC11,800$60.0K0.01%+11,800New
Bank of New York Mellon Corp11,418$58.0K0.00%+11,418New
Morgan Stanley5,641$29.0K0.00%+3,219+132.9%Added
Penserra Capital Management LLC4,699$23.0K0.00%−1,353−22.4%Reduced
Roble, Belko & Company, Inc4,502$23.0K0.00%00.0%Unchanged
BerganKDV Wealth Management, LLC4,500$23.0K0.00%00.0%Unchanged
Gleason Group, Inc.4,250$21.0K0.01%+4,250New
UBS Group AG3,292$17.0K0.00%−1,077−24.7%Reduced
Washington Trust Advisors, Inc.3,000$15.0K0.00%00.0%Unchanged
Ovata Capital Management Ltd2,100$11.0K0.00%+2,100New
JPMorgan Chase & Co1,400$7.00K0.00%+1,400New
Tower Research Capital LLC (TRC)728$4.00K0.00%−4,529−86.2%Reduced
Patriot Financial Group Insurance Agency, LLC500$3.00K0.00%00.0%Unchanged
Wells Fargo & Company212$1.00K0.00%+212New
Sandy Cove Advisors, LLC100$1.00K0.00%+100New
DuPont Capital Management Corp2$00.00%00.0%Unchanged
Citigroup Inc50$00.00%+50New
Ergoteles LLC0$00.00%−36,300−100.0%Sold out
Advisor Group Holdings, Inc.0$00.00%−914−100.0%Sold out
Concord Wealth Partners0$00.00%−1,000−100.0%Sold out